Abstract
γ-Secretase has been a therapeutical target for its key role in cleaving APP to generate β-amyloid (Aβ), the primary constituents of senile plaques and a hallmark of Alzheimer’s disease (AD) pathology. Recently, γ-secretase-associating proteins showed promising role in specifically modulating APP processing while sparing Notch signaling; however, the underlying mechanism is still unclear. A co-immunoprecipitation (Co-IP) coupled with mass spectrometry proteomic assay for Presenilin1 (PS1, the catalytic subunit of γ-secretase) was firstly conducted to find more γ-secretase-associating proteins. Gene ontology analysis of these results identified Rab21 as a potential PS1 interacting protein, and the interaction between them was validated by reciprocal Co-IP and immunofluorescence assay. Then, molecular and biochemical methods were used to investigate the effect of Rab21 on APP processing. Results showed that overexpression of Rab21 enhanced Aβ generation, while silencing of Rab21 reduced the accumulation of Aβ, which resulted due to change in γ-secretase activity rather than α- or β-secretase. Finally, we demonstrated that Rab21 had no effect on γ-secretase complex synthesis or metabolism but enhanced PS1 endocytosis and translocation to late endosome/lysosome. In conclusion, we identified a novel γ-secretase-associating protein Rab21 and illustrate that Rab21 promotes γ-secretase internalization and translocation to late endosome/lysosome. Moreover, silencing of Rab21 decreases the γ-secretase activity in APP processing thus production of Aβ. All these results open new gateways towards the understanding of γ-secretase-associating proteins in APP processing and make inhibition of Rab21 a promising strategy for AD therapy.
Similar content being viewed by others
Abbreviations
- Aβ:
-
β-amyloid
- AD:
-
Alzheimer’s disease
- APP:
-
Amyloid precursor protein
- APP-CTF:
-
C-Terminal Fragment of APP
- Aph1:
-
anterior pharynx-defective 1
- BACE1:
-
β-site APP cleaving enzyme 1
- Co-IP:
-
co-immunoprecipitation
- CALM/PICALM:
-
phosphatidylinositol binding clathrin assembly protein
- EE:
-
Early endosome
- EEA1:
-
Early endosome antigen1
- FAD:
-
familial Alzheimer’s disease
- PS1:
-
Presenilin1
- PS1-FL:
-
Full length Presenilin1
- PS1-CT:
-
C terminus of Presenilin1
- PS1-NT:
-
N terminus of Presenilin1
- PEN2:
-
Presenilin enhancer-2
- NCT:
-
Nicastrin
- LAMP1:
-
Lysosome-associated membrane protein1
- LE:
-
Late endosome
- shRNA:
-
short hairpin RNA
- shRab21:
-
short hairpin RNA of Rab21
- TGN:
-
trans Golgi network.
References
Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer Report 2016, Improving healthcare for people living with dementia: Coverage, quality and costs now and in the future. Alzheimers Dis Int 1–140
Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol Sci 12(10):383–388
Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM (2016) Alzheimer’s disease. Lancet 388(10043):505–517. doi:10.1016/s0140-6736(15)01124-1
Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, Ihara Y (2009) Gamma-secretase: Successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29(41):13042–13052. doi:10.1523/JNEUROSCI.2362-09.2009
De Strooper B (2003) Aph-1, pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex. Neuron 38(1):9–12
Piaceri I, Nacmias B, Sorbi S (2013) Genetics of familial and sporadic Alzheimer’s disease. Front Biosci 5:167–177
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, Prada CM, Kim G et al (1996) Familial Alzheimer’s disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron 17(5):1005–1013
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J et al (1996) Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nat Med 2(8):864–870
De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, Von Figura K, Van Leuven F (1998) Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391(6665):387–390. doi:10.1038/34910
Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C, Spittaels K, Umans L et al (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22(9):3445–3453 doi: 20026290
Bergmans BA, De Strooper B (2010) Gamma-secretases: From cell biology to therapeutic strategies. Lancet Neurol 9(2):215–226
Imbimbo BP, Panza F, Frisardi V, Solfrizzi V, D’Onofrio G, Logroscino G, Seripa D, Pilotto A (2011) Therapeutic intervention for Alzheimer’s disease with gamma-secretase inhibitors: Still a viable option? Expert Opin Investig Drugs 20(3):325–341. doi:10.1517/13543784.2011.550572
Albright CF, Dockens RC, Meredith JE Jr, Olson RE, Slemmon R, Lentz KA, Wang JS, Denton RR et al (2013) Pharmacodynamics of selective inhibition of gamma-secretase by avagacestat. J Pharmacol Exp Ther 344(3):686–695. doi:10.1124/jpet.112.199356
Coric V, van Dyck CH, Salloway S, Andreasen N, Brody M, Richter RW, Soininen H, Thein S et al (2012) Safety and tolerability of the gamma-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease. Arch Neurol 69(11):1430–1440. doi:10.1001/archneurol.2012.2194
Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, Curtis C, Soininen H et al (2015) Targeting prodromal Alzheimer disease with Avagacestat: A randomized clinical trial. JAMA Neurol 72(11):1324–1333. doi:10.1001/jamaneurol.2015.0607
Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, He F et al (2013) A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N Engl J Med 369(4):341–350. doi:10.1056/NEJMoa1210951
Karran E, Hardy J (2014) A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann Neurol 76(2):185–205. doi:10.1002/ana.24188
Crump CJ, Castro SV, Wang F, Pozdnyakov N, Ballard TE, Sisodia SS, Bales KR, Johnson DS et al (2012) BMS-708, 163 targets presenilin and lacks notch-sparing activity. Biochemistry 51(37):7209–7211. doi:10.1021/bi301137h
Chavez-Gutierrez L, Bammens L, Benilova I, Vandersteen A, Benurwar M, Borgers M, Lismont S, Zhou L et al (2012) The mechanism of gamma-secretase dysfunction in familial Alzheimer disease. EMBO J 31(10):2261–2274. doi:10.1038/emboj.2012.79
De Strooper B (2014) Lessons from a failed gamma-secretase Alzheimer trial. Cell 159(4):721–726. doi:10.1016/j.cell.2014.10.016
McCarthy JV, Twomey C, Wujek P (2009) Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cell Mol Life Sci 66(9):1534–1555. doi:10.1007/s00018-009-8435-9
Wakabayashi T, De Strooper B (2008) Presenilins: Members of the gamma-secretase quartets, but part-time soloists too. Physiology (Bethesda) 23:194–204. doi:10.1152/physiol.00009.2008
Ni Y, Zhao X, Bao G, Zou L, Teng L, Wang Z, Song M, Xiong J et al (2006) Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med 12(12):1390–1396. doi:10.1038/nm1485
Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horre K, Vanbrabant M, Coun F et al (2009) The orphan G protein-coupled receptor 3 modulates amyloid-Beta peptide generation in neurons. Science 323(5916):946–951. doi:10.1126/science.1160649
Kanatsu K, Morohashi Y, Suzuki M, Kuroda H, Watanabe T, Tomita T, Iwatsubo T (2014) Decreased CALM expression reduces Abeta42 to total Abeta ratio through clathrin-mediated endocytosis of gamma-secretase. Nat Commun 5:3386. doi:10.1038/ncomms4386
De Strooper B, Annaert W (2010) Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu Rev Cell Dev Biol 26:235–260. doi:10.1146/annurev-cellbio-100109-104117
Jiang S, Li Y, Zhang X, Bu G, Xu H, Y-w Z (2014) Trafficking regulation of proteins in Alzheimer’s disease. Mol Neurodegener 9:6. doi:10.1186/1750-1326-9-6
Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, Callahan JW, Mahuran DJ (2003) Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane. J Biol Chem 278(29):26687–26694. doi:10.1074/jbc.M212192200
Teng L, Zhao J, Wang F, Ma L, Pei G (2010) A GPCR/secretase complex regulates beta- and gamma-secretase specificity for a beta production and contributes to AD pathogenesis. Cell Res 20(2):138–153. doi:10.1038/cr.2010.3
Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S et al (2012) [beta]-arrestin 2 regulates a [beta] generation and [gamma]-secretase activity in Alzheimer’s disease. Nat Med 19:43–49
Sannerud R, Esselens C, Ejsmont P, Mattera R, Rochin L, Tharkeshwar AK, De Baets G, De Wever V et al (2016) Restricted location of PSEN2/gamma-secretase determines substrate specificity and generates an intracellular Abeta pool. Cell 166(1):193–208. doi:10.1016/j.cell.2016.05.020
Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, Gu Y, Sanjo N et al (2006) TMP21 is a presenilin complex component that modulates [gamma]-secretase but not [epsiv]-secretase activity. Nature 440(7088):1208–1212 http://www.nature.com/nature/journal/v440/n7088/suppinfo/nature04667_S1.html
Bromley-Brits K, Song WH (2012) The role of TMP21 in trafficking and amyloid-beta precursor protein (APP) processing in Alzheimer’s disease. Curr Alzheimer Res 9(4):411–424
Ginsberg SD, Alldred MJ, Counts SE, Cataldo AM, Neve RL, Jiang Y, Wuu J, Chao MV et al (2010) Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer’s disease progression. Biol Psychiatry 68(10):885–893. doi:10.1016/j.biopsych.2010.05.030
Ginsberg SD, Mufson EJ, Counts SE, Wuu J, Alldred MJ, Nixon RA, Che S (2010) Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer’s disease. Journal of Alzheimer’s disease: JAD 22(2):631–639. doi:10.3233/jad-2010-101080
Grbovic OM, Mathews PM, Jiang Y, Schmidt SD, Dinakar R, Summers-Terio NB, Ceresa BP, Nixon RA et al (2003) Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production. J Biol Chem 278(33):31261–31268. doi:10.1074/jbc.M304122200
Udayar V, Buggia-Prevot V, Guerreiro RL, Siegel G, Rambabu N, Soohoo AL, Ponnusamy M, Siegenthaler B et al (2013) A paired RNAi and RabGAP overexpression screen identifies Rab11 as a regulator of beta-amyloid production. Cell Rep 5(6):1536–1551. doi:10.1016/j.celrep.2013.12.005
Dumanchin C, Czech C, Campion D, Cuif MH, Poyot T, Martin C, Charbonnier F, Goud B et al (1999) Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport. Hum Mol Genet 8(7):1263–1269
Jean S, Cox S, Schmidt EJ, Robinson FL, Kiger A (2012) Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling. Mol Biol Cell 23(14):2723–2740. doi:10.1091/mbc.E12-05-0375
Ali M, Leung KF, Field MC (2014) The ancient small GTPase Rab21 functions in intermediate endocytic steps in trypanosomes. Eukaryot Cell 13(2):304–319. doi:10.1128/ec.00269-13
Jean S, Cox S, Nassari S, Kiger AA (2015) Starvation-induced MTMR13 and RAB21 activity regulates VAMP8 to promote autophagosome-lysosome fusion. EMBO Rep 16(3):297–311. doi:10.15252/embr.201439464
Pellinen T, Tuomi S, Arjonen A, Wolf M, Edgren H, Meyer H, Grosse R, Kitzing T et al (2008) Integrin trafficking regulated by Rab21 is necessary for cytokinesis. Dev Cell 15(3):371–385. doi:10.1016/j.devcel.2008.08.001
Simpson JC, Griffiths G, Wessling-Resnick M, Fransen JAM, Bennett H, Jones AT (2004) A role for the small GTPase Rab21 in the early endocytic pathway. J Cell Sci 117(26):6297–6311. doi:10.1242/jcs.01560
Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B, Naslund J (2003) Partial purification and characterization of gamma-secretase from post-mortem human brain. J Biol Chem 278(27):24277–24284. doi:10.1074/jbc.M211992200
Waugh MG (2013) Raft-like membranes from the trans-Golgi network and endosomal compartments. Nat Protoc 8(12):2429–2439. doi:10.1038/nprot.2013.148
Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H et al (2004) Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279(43):44945–44954. doi:10.1074/jbc.M407986200
Fukumori A, Okochi M, Tagami S, Jiang J, Itoh N, Nakayama T, Yanagida K, Ishizuka-Katsura Y et al (2006) Presenilin-dependent gamma-secretase on plasma membrane and endosomes is functionally distinct. Biochemistry 45(15):4907–4914. doi:10.1021/bi052412w
Yang X, Zhang Y, Li S, Liu C, Jin Z, Wang Y, Ren F, Chang Z (2012) Rab21 attenuates EGF-mediated MAPK signaling through enhancing EGFR internalization and degradation. Biochem Biophys Res Commun 421(4):651–657. doi:10.1016/j.bbrc.2012.04.049
Buggia-Prevot V, Fernandez CG, Riordan S, Vetrivel KS, Roseman J, Waters J, Bindokas VP, Vassar R et al (2014) Axonal BACE1 dynamics and targeting in hippocampal neurons: A role for Rab11 GTPase. Mol Neurodegener 9:1. doi:10.1186/1750-1326-9-1
Lopez-Perez E, Dumanchin C, Czech C, Campion D, Goud B, Pradier L, Frebourg T, Checler F (2000) Overexpression of Rab11 or constitutively active Rab11 does not affect sAPPalpha and Abeta secretions by wild-type and Swedish mutated betaAPP-expressing HEK293 cells. Biochem Biophys Res Commun 275(3):910–915. doi:10.1006/bbrc.2000.3404
Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of a beta 42(43) and a beta 40 in senile plaques with end-specific a beta monoclonals: Evidence that an initially deposited species is a beta 42(43). Neuron 13(1):45–53
Li N, Liu K, Qiu Y, Ren Z, Dai R, Deng Y, Qing H (2016) Effect of Presenilin mutations on APP cleavage; insights into the pathogenesis of FAD. Front Aging Neurosci 8:51. doi:10.3389/fnagi.2016.00051
Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I et al (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature 360(6405):672–674. doi:10.1038/360672a0
Huang Y, Skwarek-Maruszewska A, Horre K, Vandewyer E, Wolfs L, Snellinx A, Saito T, Radaelli E et al (2015) Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer’s disease mouse models. Sci Transl Med 7(309):309ra164. doi:10.1126/scitranslmed.aab3492
Emmanuel M, Nakano YS, Nozaki T, Datta S (2015) Small GTPase Rab21 mediates fibronectin induced actin reorganization in Entamoeba histolytica: Implications in pathogen invasion. PLoS Pathog 11(3):e1004666. doi:10.1371/journal.ppat.1004666
Nagano M, Toshima JY, Toshima J (2015) Rab GTPases networks in membrane traffic in Saccharomyces cerevisiae. Yakugaku zasshi : J Pharm Soc Jpn 135(3):483–492. doi:10.1248/yakushi.14-00246
Feng Y, Press B, Wandinger-Ness A (1995) Rab 7: An important regulator of late endocytic membrane traffic. J Cell Biol 131(6 Pt 1):1435–1452
Guerra F, Bucci C (2016) Multiple roles of the small GTPase Rab7. Cell 5(3). doi:10.3390/cells5030034
Mai A, Veltel S, Pellinen T, Padzik A, Coffey E, Marjomaki V, Ivaska J (2011) Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor traffic and migration. J Cell Biol 194(2):291–306. doi:10.1083/jcb.201012126
Acknowledgements
We thank Talal Jamil Qazi and Kefu Liu for their help in manuscript drafting. This study was supported by the National Natural Science Foundation of China (81671268), the National Key Scientific Instrument and Equipment Development Project (2013YQ03059514), China Postdoctoral Science Foundation funded project (2016M600931), and a grant from Beijing municipal science and technology commission (Z161100002616020).
Author information
Authors and Affiliations
Contributions
Zhenzhen Sun and Hong Qing designed the study. Zhenzhen Sun, Yujie Xie, and Yintong Chen performed the experiment. Zhenzhen Sun analyzed the data and wrote the manuscript. Qinghu Yang and Zhenzhen Quan helped to revise the manuscript. Dai Rongji provided assistance in data analysis.
Corresponding author
Ethics declarations
Competing Interests
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Sun, Z., Xie, Y., Chen, Y. et al. Rab21, a Novel PS1 Interactor, Regulates γ-Secretase Activity via PS1 Subcellular Distribution. Mol Neurobiol 55, 3841–3855 (2018). https://doi.org/10.1007/s12035-017-0606-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-017-0606-3